SECTION I: TYPE-2 DIABETES: PREVALENCE AND SIGNIFICANCE 1. Type-2 diabetes: definition, diagnosis and significance SECTION II: NORMAL PHYSIOLOGICAL CONTROL OF CARBOHYDRATE AND LIPID METABOLISM AND SOME COMMON ANTIDIABETIC THERAPEUTIC TARGETS 2. Glucose metabolism: normal physiology, diabetic dysregulation and therapeutic targets 3. Lipid metabolism: normal physiology, dysregulation under obesity and diabetes, and therapeutic targets SECTION III: PATHOPHYSIOLOGY OF TYPE-2 DIABETES AND THERAPEUTIC OPTIONS 4. Pathophysiology of type-2 diabetes complications 5. Current pharmacotherapy options for type-2 diabetes 6. Introduction to plant secondary metabolites - from biosynthesis to chemistry and antidiabetic action SECTION IV: POTENTIAL MODULATORS OF TYPE-2 DIABETES AND ASSOCIATED DISEASES: SUPER FRUIT 7. Bilberry and blueberries as potential modulators of type 2 diabetes and associated diseases 8.
The chemical and pharmacological basis of bitter melon (momordica charantia l.) as a potential therapy for type 2 diabetes and associated diseases 9. The chemical and pharmacological basis of guava (psidium guajava l.) as potential therapy for type 2 diabetes and associated diseases 10. The chemical and pharmacological basis of okra (abelmoschus esculentus (l.) Moench) as potential therapy for type 2 diabetes 11. The chemical and pharmacological basis of papaya (carica papaya l.) as potential therapy for type 2 diabetes and associated diseases 12.
The chemical and pharmacological basis of pomegranate (punica grantum l) as potential therapy for type-2 diabetes and metabolic syndrome 13. The chemical and pharmacological basis of prickly pear cactus (opuntia species) as potential therapy for type 2 diabetes and obesity 14. The chemical and pharmacological basis of pumpkins (cucurbita species) as potential therapy for type 2 diabetes SECTION V: POTENTIAL MODULATORS OF TYPE-2 DIABETES AND ASSOCIATED DISEASES: SPICES 15. The chemical and pharmacological basis of cinnamon (cinnamomum species) as potential therapy for type 2 diabestes and associated diseases 16. The chemical and pharmacological basis of cloves (syzygium aromaticum (l.) Merr. & l.m.
perry) as potential therapy for type 2 diabestes and associated diseases 17. The chemical and pharmacological basis of fenugreek (trigonella foenum-graecum l.) as potential therapy for type 2 diabestes and associated diseases 18. The chemical and pharmacological basis of ginger (zingiber officinale roscoe) as potential therapy for diabetes and metabolic syndrome 19. The chemical and pharmacological basis of garlic (allium sativum l.) as potential therapy for diabetes and metabolic syndrome 20. The chemical and pharmacological basis of turmeric (curcuma longa l.) as potential therapy for type 2 diabetes and metabolic syndrome SECTION VI: POTENTIAL MODULATORS OF TYPE 2 DIABETES AND ASSOCIATED DISEASS: BEVERAGES, OTHER FOODS AND HERBAL SUPPLEMENTS 21.
Chemical and pharmacological evidences for coffee as a modulator of type 2 diabetes and metabolic syndrome 22. The chemical and pharmacological basis of tea (camellia sinensis (l.) Kuntze) as potential therapy for diabetes and metabolic syndrome 23. The chemical and pharmacological basis of rooibos (aspalathus linearis (burm.f.) r.dahlgren) as potential therapy for diabetes and metabolic syndrome 24. The chemical and pharmacological basis of yerba maté (ilex paraguariensis a.
st.-hil.) as potential therapy for diabetes and metabolic syndrome 25. Other common and exotic foods with growing importance as antidiabetic agents 26. Antidibetic herbal medicines rebranded as dietary supplements.